Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

62443 Press Releases
DateTitleCompany
09 Jan 12 Clovis Oncology Announces Size of Initial hENT1-Low Population in Pivotal LEAP Trial and Provides Financial Guidance for 2012 Clovis Oncology Inc.,
Published by
Business Wire
09 Jan 12 Progel® Adhesion Barrier Sealant Receives CE Mark Neomend Inc.,
Published by
Business Wire
09 Jan 12 Emergent BioSolutions Provides Preliminary 2011 Financial Results and Provides Guidance for 2012 Emergent BioSolutions Inc.,
Published by
Business Wire
09 Jan 12 New Company, Aerpio Therapeutics, Created to Advance Novel Tie-2 Activators and HIF-1a Stabilizers for Multiple Diseases Aerpio Therapeutics,
Published by
Business Wire
09 Jan 12 Akebia Draws Down $4.1 Million Series B Financing Tranche Akebia Therapeutics Inc.,
Published by
Business Wire
09 Jan 12 Advanced Cell Technology To Present in the Regenerative Medicine Insight Track at the Biotech Showcase™ 2012 in San Francisco Advanced Cell Technology Inc.,
Published by
Business Wire
09 Jan 12 US Interventional Cardiology Device Market Will Shrink by Three Percent Per Year Through 2016 Millennium Research Group,
Published by
Business Wire
09 Jan 12 Kyorin and BioLeap Enter Research Collaboration BioLeap Inc.,
Published by
Business Wire
09 Jan 12 Pathwork® Tissue of Origin Test Cost-Effective for Increasing Cancer Patient Survival Pathwork Diagnostics Inc.,
Published by
Business Wire
09 Jan 12 Interleukin Genetics, Inc. to Present at Biotech Showcase™ 2012 Interleukin Genetics Inc.,
Published by
Business Wire
09 Jan 12 RegeneRx Issued Major U.S. Heart Patent RegeneRx Biopharmaceuticals Inc.,
Published by
Business Wire
09 Jan 12 Next IT Expands Bench of Pharmaceutical Industry Expertise Next IT,
Published by
Business Wire
09 Jan 12 New Online Game, 'Brain Swaggle,' Combines Chess with Scrabble to Sharpen Vocabulary, Strategy and Cognitive Skills ERELEASES,
Published by
PR Newswire
09 Jan 12 RBCC: Houston Blossoming With Potential Customers for Bio-Assembler Rainbow Coral Corp.,
Published by
Business Wire
09 Jan 12 Acorda Therapeutics Provides 2012 Corporate Update at 30th Annual J.P. Morgan Healthcare Conference Acorda Therapeutics Inc.,
Published by
Business Wire
09 Jan 12 Pacira Pharmaceuticals, Inc. Provides Update on Commercial Launch and Product Availability Timing for EXPAREL® Pacira Pharmaceuticals Inc.,
Published by
Business Wire
09 Jan 12 Presidio Pharmaceuticals Reports Progress with Hepatitis C Antiviral Programs Presidio Pharmaceuticals Inc.,
Published by
Business Wire
09 Jan 12 LATEST CQC INSPECTION CONFIRMS KING EDWARD VII’s HOSPITAL CONTINUES TO SET HIGHEST STANDARDS OF CARE King Edward VII Hospital,
Published by
Media Zoo
09 Jan 12 Silence Therapeutics signs collaboration with miRagen Therapeutics to evaluate delivery of novel microRNA-based therapeutics Silence Therapeutics
09 Jan 12 ICON Selected by Shire plc’s Specialty Pharmaceuticals division as Global Strategic Partner for Clinical Research and Central Laboratory Services ICON plc
09 Jan 12 BerGenBio Completes $9 Million Series A Financing for First in Class Oncology Therapeutics BerGenBio AS,
Published by
Business Wire
09 Jan 12 Recipharm enables PledPharma to re-start myocardial infarction trial following approval from the Swedish Medical Products Agency Recipharm
09 Jan 12 MDxHealth Receives 2011 European Molecular Diagnostics for Oncology Technology Leadership Award MDxHealth,
Published by
Business Wire
09 Jan 12 EpiCept Corporation Engages SunTrust Robinson Humphrey to Advise on Strategy to Maximize AmiKet™ Potential EpiCept Corporation,
Published by
Business Wire
09 Jan 12 Vertex Announces Key 2012 Business Objectives as Company Prepares for Planned Global Launch of KALYDECO in Cystic Fibrosis Vertex Pharmaceuticals Incorporated,
Published by
Business Wire
09 Jan 12 BioCryst Announces Positive Results from Its Ongoing BCX4208 Phase 2B Study in Patients with Gout BioCryst Pharmaceuticals Inc.,
Published by
Business Wire
09 Jan 12 Alnylam Provides Key 2012 Goals for RNAi Therapeutics Pipeline Alnylam Pharmaceuticals,
Published by
Business Wire
09 Jan 12 Colby Pharmaceutical Company Announces Publication of JVRS-100 use as Potent Immune Activating Adjuvant in Combination with H5N1 Influenza Vaccine Colby Pharmaceutical Company,
Published by
Business Wire
09 Jan 12 ICON Selected by Shire plc’s Specialty Pharmaceuticals division as Global Strategic Partner for Clinical Research and Central Laboratory Services ICON plc,
Published by
Business Wire
08 Jan 12 Expert plastic surgeon offers free removal of PIP implants Total Health World Ltd
Advertising